Aiko Sato-Otsubo Selected Research

Aiko Sato-Otsubo Research Topics

Disease

10	Neoplasms (Cancer) 11/2022 - 05/2013
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 05/2013
1	Carcinogenesis 01/2022
1	Neuroblastoma 01/2022
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2020
1	Hyperplasia 12/2018
1	Splenomegaly 12/2018
1	Infections 07/2017
1	Hematologic Neoplasms (Hematological Malignancy) 07/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2016
1	Fibrosis (Cirrhosis) 09/2015
1	Reperfusion Injury 09/2015
1	Necrosis 09/2015
1	Acute Kidney Injury (Acute Renal Failure) 09/2015
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2015
1	Congenital Bone Marrow Failure Syndromes 03/2015
1	Adrenocortical Adenoma (Disease, Conn's) 05/2014
1	Cushing Syndrome 05/2014
1	Uveitis 05/2014
1	Takayasu Arteritis (Arteritis, Takayasu's) 08/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2013
1	Bone Marrow Failure Disorders 12/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2012
1	Cryopyrin-Associated Periodic Syndromes 08/2012
1	Genomic Instability 04/2012
1	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 03/2012

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 06/2015
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2012
2	Biological ProductsIBA 01/2022 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 08/2012
2	HLA-B Antigens (HLA-B)IBA 04/2016 - 08/2013
1	Cell-Free Nucleic AcidsIBA 11/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2018
1	Heme (Haem)IBA 01/2018
1	IronIBA 01/2018
1	Toll-Like Receptor 2IBA 07/2017
1	Toll-Like Receptor 4IBA 07/2017
1	Toll-Like Receptor 1IBA 07/2017
1	taxaneIBA 01/2017
1	AnthracyclinesIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2017
1	HLA-A Antigens (HLA-A)IBA 10/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2016
1	HLA-C Antigens (HLA-C)IBA 04/2016
1	Guanosine Triphosphate (GTP)IBA 02/2016
1	CreatinineIBA 09/2015
1	Urea (Carbamide)FDA LinkGeneric 09/2015
1	NitrogenIBA 09/2015
1	Immunoglobulin G (IgG)IBA 06/2015
1	DiamondIBA 03/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2014
1	Adenosine Monophosphate (AMP)IBA 05/2014
1	Interleukin-10 (Interleukin 10)IBA 05/2014
1	CohesinsIBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Fluorouracil (Carac)FDA LinkGeneric 05/2013
1	Epirubicin (Ellence)FDA LinkGeneric 05/2013
1	Estrogen ReceptorsIBA 05/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2013
1	Trastuzumab (Herceptin)FDA Link 05/2013
1	Lapatinib (GW572016)FDA Link 05/2013
1	Hormones (Hormone)IBA 05/2013
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 12/2012
1	Indicators and Reagents (Reagents)IBA 04/2012
1	Ribosomal Proteins (Ribosomal Protein)IBA 03/2012

Therapy/Procedure

3	Therapeutics 01/2017 - 05/2014
2	Transplantation 12/2018 - 09/2015
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2017 - 04/2016
2	Neoadjuvant Therapy 01/2017 - 05/2013
1	Hematopoietic Stem Cell Transplantation 04/2016
1	Donor Selection 04/2016
1	Stem Cell Transplantation 12/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2015
1	Critical Care (Surgical Intensive Care) 09/2015
1	Drug Therapy (Chemotherapy) 05/2013